Electronic medical device manufacturer secures buyer for two key subsidiaries in the US and Morocco
Deal Flash
Cicor Group has acquired the US and Moroccan subsidiaries of Valtronic. Through this transaction, Valtronic’s shareholders have secured the long-term development and success of the two entities, while Cicor gains access to the US market, doubles its production capacity in Morocco, and further strengthens its global EMS platform.
Cicor Group, a Swiss publicly listed provider of advanced electronics manufacturing services and substrate solutions, operates around 30 sites worldwide. Serving the healthcare technology, industrial electronics and aerospace & defense sectors, the company combines engineering excellence with high-precision production to deliver full-cycle solutions ranging from development and design to advanced electronics manufacturing and supply-chain management.
Headquartered in Switzerland, Valtronic was founded in 1982 and today employs more than 350 people. The company is a full-service electronic medical device contract manufacturer, covering the entire product life cycle from concept to final production. Its expertise includes microelectronic assemblies, complex PCBA assemblies, as well as complete device builds.
Valtronic has established itself as a highly respected provider of advanced electronic medical device solutions, built on long-standing customer partnerships. With the acquisition of its US and Moroccan operations by Cicor, the long-term and sustainable growth trajectory of these subsidiaries will continue in the spirit of their former owners. We would like to thank the owners of Valtronic for their trust in allowing us to support them through this important milestone.DAVID ZÜRRER, PARTNER, OAKLINS SWITZERLAND
Oaklins played a pivotal role in arranging this deal
Oaklins Switzerland acted as the exclusive M&A advisor to Valtronic. The team leveraged its deep expertise in the medtech sector to support the shareholders and management of Valtronic throughout the sale process.
Talk to our advisor
Partner
View profile
Read more about the transaction, market trends, deal drivers and M&A valuation aspects
